Opportunity Information: Apply for SP 21 001
The Strategic Prevention Framework for Prescription Drugs (SPF Rx) is a discretionary grant program from the U.S. Department of Health and Human Services, administered by SAMHSA through its Center for Substance Abuse Prevention (CSAP). Released as a FY 2021 funding opportunity (Opportunity Number SP 21 001; CFDA 93.243), the program is aimed at strengthening statewide and Tribal prevention systems specifically focused on reducing prescription drug misuse, with a strong emphasis on opioids and overdose prevention. The overall intent is to help eligible jurisdictions use a structured prevention planning model to identify drivers of prescription drug misuse, select evidence-based strategies, and coordinate partners across public health, education, and healthcare to reduce harms.
Eligibility is targeted rather than broad. The opportunity is designed for states and U.S. territories (referred to in the notice collectively as "states") and for Tribal entities that have already completed a Strategic Prevention Framework State Incentive Grant (SPF SIG), or that have completed another comparable state-level strategic planning process focused on prescription drug misuse prevention. In other words, this funding is meant to build on an existing foundation of prevention infrastructure and planning capacity, not to start from scratch. The eligible applicant category is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the narrative makes clear that the primary intended applicants are states, territories, and Tribal entities with prior SPF SIG experience or an equivalent planning background in prescription drug misuse prevention.
Programmatically, SPF Rx centers on changing community and system conditions that contribute to misuse, rather than relying only on individual-level messaging. A major theme is raising awareness about the risks and consequences of sharing prescription medications, which is a common pathway into misuse for adolescents and young adults. Alongside public awareness, the program explicitly prioritizes engagement with the pharmaceutical and medical communities, particularly to address the risks of overprescribing to young adults and to promote safer prescribing practices. This means applicants are expected to work collaboratively with prescribers, healthcare systems, and related professional stakeholders, not only with traditional prevention partners.
The grant also emphasizes broad, community-facing prevention education and activities that reach multiple audiences. The description highlights delivering prescription drug abuse prevention efforts to schools and community settings and directly engaging parents, prescribers, and patients. That framing signals an expectation of coordinated, multi-sector outreach where consistent prevention messages and practices reinforce one another across settings where medication decisions are made, medications are stored, and youth and families receive information.
SAMHSA describes success in measurable, outcome-oriented terms. Two indicators are explicitly referenced: reductions in opioid overdoses and the incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans. The inclusion of PDMP integration is important because it points to a data-driven approach to prevention planning and monitoring, where jurisdictions are expected to use real-world prescribing and dispensing data to identify hotspots, emerging trends, and priority populations, then reflect that analysis in formal prevention plans and strategy selection.
From an administrative perspective, the opportunity was posted March 1, 2021, with an original application closing date of April 30, 2021. SAMHSA projected 26 awards, and the listed award ceiling is $384,000. The funding instrument is a grant, and the activity category is health. Overall, SPF Rx can be understood as a targeted prevention investment meant to help states, territories, and eligible Tribal entities translate prior prevention planning capacity into focused action on prescription drug misuse, align community education with healthcare practice change, and use PDMP and overdose data to guide strategy and demonstrate impact.Apply for SP 21 001
- The Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis in the health sector is offering a public funding opportunity titled "Strategic Prevention Framework for Prescription Drugs" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243.
- This funding opportunity was created on Mar 01, 2021.
- Applicants must submit their applications by Apr 30, 2021. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $384,000.00 in funding.
- The number of recipients for this funding is limited to 26 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Strategic Prevention Framework for Prescription Drugs (SPF Rx) - FAQs
1) What is the SPF Rx grant program?
The Strategic Prevention Framework for Prescription Drugs (SPF Rx) is a discretionary grant program from the U.S. Department of Health and Human Services (HHS). It is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) through SAMHSA's Center for Substance Abuse Prevention (CSAP). The program is designed to strengthen statewide and Tribal prevention systems focused on reducing prescription drug misuse, with a strong emphasis on opioids and overdose prevention.
2) What is the official funding opportunity identifier for this program?
The opportunity was released as a FY 2021 funding opportunity with Opportunity Number SP 21 001 and CFDA 93.243.
3) What is the main purpose of SPF Rx?
The main purpose is to help eligible jurisdictions use a structured prevention planning model to identify key drivers of prescription drug misuse, select evidence-based prevention strategies, and coordinate partners across sectors (including public health, education, and healthcare) to reduce harms related to prescription drug misuse.
4) What types of applicants are eligible to apply?
Eligibility is targeted to states and U.S. territories (referred to collectively in the notice as "states") and Tribal entities that have already completed a Strategic Prevention Framework State Incentive Grant (SPF SIG), or that have completed another comparable state-level strategic planning process focused on prescription drug misuse prevention.
5) Does this funding support jurisdictions that are starting prevention planning from scratch?
No. The opportunity is meant to build on an existing foundation of prevention infrastructure and planning capacity. It is intended for jurisdictions that already have prior SPF SIG experience or an equivalent planning background focused on prescription drug misuse prevention.
6) The eligibility category says "Others." What does that mean here?
Although the eligible applicant category is listed as "Others (see text field entitled Additional Information on Eligibility for clarification)," the narrative indicates the primary intended applicants are states, territories, and eligible Tribal entities with prior SPF SIG experience or an equivalent state-level planning background in prescription drug misuse prevention.
7) What prevention approach does SPF Rx emphasize?
SPF Rx emphasizes changing community and system conditions that contribute to prescription drug misuse, rather than relying only on individual-level messaging. The program is oriented around structured prevention planning and system-level coordination.
8) Is opioid prevention a focus of this grant?
Yes. The program has a strong emphasis on opioids and overdose prevention, and one of the explicitly referenced indicators of success is reductions in opioid overdoses.
9) What role does public awareness play in SPF Rx?
Public awareness is a major theme, including raising awareness about the risks and consequences of sharing prescription medications. The opportunity notes that sharing medications is a common pathway into misuse for adolescents and young adults.
10) Who are the priority audiences mentioned in the opportunity?
The description highlights reaching multiple audiences through broad, community-facing prevention education and activities. It specifically mentions schools and community settings and direct engagement of parents, prescribers, and patients.
11) Does SPF Rx require collaboration with healthcare and medical partners?
Yes. The program explicitly prioritizes engagement with the pharmaceutical and medical communities, including collaboration with prescribers, healthcare systems, and related professional stakeholders.
12) What healthcare practice issues are highlighted?
The opportunity particularly calls attention to addressing risks of overprescribing to young adults and promoting safer prescribing practices, signaling an expectation of healthcare practice change alongside community prevention education.
13) What settings are emphasized for prevention education and activities?
The opportunity highlights delivering prescription drug abuse prevention efforts to schools and community settings, alongside coordinated outreach that reinforces consistent prevention messages and practices across multiple environments.
14) What does SAMHSA describe as measurable indicators of success?
Two indicators are explicitly referenced: (1) reductions in opioid overdoses, and (2) incorporation of Prescription Drug Monitoring Program (PDMP) data into needs assessments and strategic plans.
15) Why is PDMP data important in SPF Rx?
PDMP integration points to a data-driven approach to prevention planning and monitoring. The opportunity indicates jurisdictions are expected to use real-world prescribing and dispensing data to identify hotspots, emerging trends, and priority populations, and then reflect that analysis in needs assessments, strategic plans, and strategy selection.
16) What is the funding instrument and activity category?
The funding instrument is a grant, and the activity category is health.
17) When was the SPF Rx opportunity posted, and what was the original closing date?
The opportunity was posted on March 1, 2021, with an original application closing date of April 30, 2021.
18) How many awards were expected under this opportunity?
SAMHSA projected 26 awards.
19) What is the maximum award amount listed for SPF Rx?
The listed award ceiling is $384,000.
20) In plain terms, what is SPF Rx trying to help jurisdictions do?
Overall, SPF Rx is a targeted prevention investment meant to help eligible states, territories, and Tribal entities translate existing prevention planning capacity into focused action on prescription drug misuse, align community education with healthcare practice change, and use PDMP and overdose-related data to guide strategies and demonstrate impact.
Browse more opportunities from the same category: Health
Next opportunity: FY2021 SBIR/STTR Phase II Release 2
Previous opportunity: Fiscal Year (FY) 2021 Nonprofit Security Grant Program (NSGP)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for SP 21 001
Applicants also applied for:
Applicants who have applied for this opportunity (SP 21 001) also looked into and applied for these:
| Funding Opportunity |
|---|
| Development of a COVID-19 Monitoring System for U.S. Correctional and Detention Facilities Apply for CDC RFA PS21 2107 Funding Number: CDC RFA PS21 2107 Agency: Department of Health and Human Services, Centers for Disease Control - NCHHSTP Category: Health Funding Amount: Case Dependent |
| Community Action for HIV Control Activity Apply for 72012121RFA00001 Funding Number: 72012121RFA00001 Agency: Agency for International Development, Ukraine USAID-Kiev Category: Health Funding Amount: $19,500,000 |
| Strengthening HIV/AIDS-related Strategic Information, Laboratory Support, and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2148 Funding Number: CDC RFA GH21 2148 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| ACL National Falls Prevention Resource Center Apply for HHS 2021 ACL AOA FPSG 0019 Funding Number: HHS 2021 ACL AOA FPSG 0019 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $1,000,000 |
| Behavioral Health Workforce Development Technical Assistance and Evaluation (BHWD TAE) Program Apply for HRSA 21 086 Funding Number: HRSA 21 086 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Preventing Violence Affecting Young Lives (PREVAYL) Apply for CDC RFA CE21 2104 Funding Number: CDC RFA CE21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $250,000 |
| State Newborn Screening Interoperability Implementation Program Apply for HRSA 21 085 Funding Number: HRSA 21 085 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Long-term Follow-up for Severe Combined Immunodeficiency and Other Newborn Screening Conditions Apply for HRSA 21 079 Funding Number: HRSA 21 079 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR Apply for CDC RFA GH21 2157 Funding Number: CDC RFA GH21 2157 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Urban Health Services and Models of Care in Kampala Capital City Authority (KCCA)- Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2158 Funding Number: CDC RFA GH21 2158 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Technical Assistance (TA) to Support the Health Information Systems (HIS) of the South African Government to Improve Patient-level Data Systems at the National and Sub-National Departments of Health (DoH) under PEPFAR Apply for CDC RFA GH21 2123 Funding Number: CDC RFA GH21 2123 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2160 Funding Number: CDC RFA GH21 2160 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP21 2101 Funding Number: CDC RFA IP21 2101 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Integrated HIV Care and Treatment Support Activity Apply for 72061321RFA00006 Funding Number: 72061321RFA00006 Agency: Agency for International Development, Zimbabwe USAID-Harare Category: Health Funding Amount: $70,000,000 |
| Advancing Health Literacy to Enhance Equitable Community Responses to COVID-19 Apply for MP CPI 21 006 Funding Number: MP CPI 21 006 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,000,000 |
| Strengthening Rocky Mountain spotted fever (RMSF) prevention and control in Arizona tribal lands Apply for CDC RFA CK21 2102 Funding Number: CDC RFA CK21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: $350,000 |
| Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA) Apply for RFA CE 21 006 Funding Number: RFA CE 21 006 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $400,000 |
| Quality Improvement Solutions for Sustained Epidemic Control Project (QISSEC) Apply for HRSA 21 096 Funding Number: HRSA 21 096 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) Apply for RFA OD 21 004 Funding Number: RFA OD 21 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) Apply for RFA OD 21 003 Funding Number: RFA OD 21 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "SP 21 001", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.